Multicenter study of the LCx® HIV RNA Quantitative Assay - A new competitive reverse transcriptase-PCR which targets pol genomic region of HIV-1 for the measurement of type B, non-type B and group O HIV-1 RNA

Clinical Chemistry and Laboratory Medicine

Volumn 40, Issue 7, 2002, Pages 698-704

  Troonen, Hugo ^a   Grey, Howard ^a   Michel, Gerd ^a   Barin, F ^a   Izopet, J ^a   Doerr, H W ^a   Knechten, H ^a   Fadda, G ^a   Gismondo, M R ^a   Zanetti, A ^a   Claas, E C J ^a   van Rensburg, E J ^a   Soriano, V ^a   Alcami, J ^a   Sonnerborg A ^a   Perrin, L ^a   Clarke, J ^a  

^a ABBOTT GMBH AND CO KG   (Germany)

Author keywords

Competitive reverse transcriptase PCR; HIV RNA; HIV 1 subtypes; Viral load

Indexed keywords

VIRUS RNA; HIV POL PROTEIN P65; POL PROTEIN;

ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORRELATION COEFFICIENT; DIAGNOSTIC ACCURACY; DIAGNOSTIC KIT; GENE TARGETING; GENETIC VARIABILITY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INTERMETHOD COMPARISON; LINEAR REGRESSION ANALYSIS; MULTICENTER STUDY; NONHUMAN; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA ANALYSIS; SAMPLE; SENSITIVITY AND SPECIFICITY; SEROLOGY; VIRUS GENOME; ACQUIRED IMMUNE DEFICIENCY SYNDROME; ANALYTICAL EQUIPMENT; BLOOD; CLASSIFICATION; COMPARATIVE STUDY; GENETICS; METHODOLOGY; REPRODUCIBILITY; STANDARD; VIRUS LOAD;

HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS 1; RNA VIRUSES;

ACQUIRED IMMUNODEFICIENCY SYNDROME; GENE PRODUCTS, POL; HIV-1; HUMANS; REAGENT KITS, DIAGNOSTIC; REPRODUCIBILITY OF RESULTS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, VIRAL; SENSITIVITY AND SPECIFICITY; VIRAL LOAD;

EID: 0036361283     PISSN: 14346621     EISSN: None     Source Type: Journal    
DOI: 10.1515/CCLM.2002.120     Document Type: Article

References (31)

1. Erroneously low or undetectable plasma human immunodeficiency virus type 1 (HIV-1) ribonucleic acid load, determined by polymerase chain reaction, in West African and American patients with non-B subtype HIV-1 infection
2. Accuracy of plasma HIV RNA quantification: A multicentre study of variability
3. Comparison of three commercial assays for the quantification of HIV-1 RNA in plasma from individuals infected with different HIV-1 subtypes
4. Genetic diversity of HIV-1 subtype F from Brazil: Failure of HIV-1 viral load testing based on molecular biology amplification methods
5. Comparison of three different commercial methods for measuring plasma viraemia in patients infected with non-B HIV-1 subtypes
6. Inaccurate HIV-1 viral load quantification by three major commercially available methods
7. HIV-1 subtypes and plasma RNA quantification
8. Understanding the genetic diversity of HIV-1
9. Estimated global distribution and regional spread of HIV-1 genetic subtypes in the year 2000
10. Travel and the introduction of human immunodeficiency virus type 1 non-B subtype genetic forms into Western countries
11. HIV subtypes: Implications for epidemiology, pathogenicity, vaccines, and diagnostics
12. Quantification of HIV-1 group M (subtypes A-G) and group O by the LCx HIV RNA quantitative assay
13. Nucleic acid primers and probes for detecting HIV-1 and HIV-2
14. A new ultrasensitive assay for quantitation of HIV-1 RNA in plasma
15. Ultrasensitive reverse transcription-PCR assay for quantitation of human immunodeficiency virus type 1 RNA in plasma
16. A branched DNA signal amplification assay for quantification of nucleic acid targets below 100 molecules/ml
17. Comparison of NucliSens and Roche Monitor assays for quantitation of levels of human immunodeficiency virus type 1 RNA in plasma
18. Immunoassays
19. Statistical methods for assessing agreement between two methods of clinical measurement
20. HIV viral load markers in clinical practice
21. Evaluation of the Abbott LCx Quantitative Assay for measurement of human immunodeficiency virus RNA in plasma
22. Comparative evaluation of the Quantiplex HIV-1 RNA 2.0 and 3.0 (bDNA) assay and the Amplicor HIV-1 Monitor v1.5 test for the quantitation of human immunodeficiency virus type 1 RNA in plasma
23. Efficiencies of four versions of the Amplicor HIV-1 Monitor test for quantification of different subtypes of human immunodeficiency virus type 1
24. Assay of plasma samples representing different HIV-1 genetic subtypes: An evaluation of new versions of the Amplicor HIV-1 Monitor assay
25. Comparative quantification of diverse serotypes of HIV-1 in plasma from a diverse population of patients
26. Comparative analysis of HIV-1 viral load assays on subtype quantification: Bayer Versant HIV-1 RNA 3.0 versus Roche Amplicor HIV-1 Monitor version 1.5
27. Clinical implications of identifying non-B subtypes of human immunodeficiency virus type 1 infection
28. Infection with non-B subtype HIV type 1 complicates management of established infection in adult patients and diagnosis of infection in newborn infants
29. Mother-to-child transmission in the United States of subtypes D and A/G human immunodeficiency virus type 1
30. Genetic diversity of HIV-1: The moving target